Work

246 Aberrations in PIK3CA, PTEN, and MAPK (KRAS, NRAS, BRAF) in 1,656 Patients and Experience with Early-phase Protocols with PI3K/AKT/mTOR Inhibitors

Year: 2012

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(12)72044-0

Authors: F. Janku, D.S. Hong, S. Fu, S.A. Piha-Paul, A. Naing, G.S. Falchook, A.M. Tsimberidou, V.M. Stepanek, J.J. Wheler, R. Kurzrock

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1992256307

FWCI: 0.513

Cites:

Cited by: 4

Related to: 10